Kadam Nakul, Acharya Sourya, Shukla Samarth, Gupta Kriti
Resident, Department of Medicine, Datta Meghe Institute of Medical Sciences University , Wardha, Maharashtra, India .
Professor, Department of Medicine, Datta Meghe Institute of Medical Sciences University , Wardha, Maharashtra, India .
J Clin Diagn Res. 2016 Apr;10(4):OC20-4. doi: 10.7860/JCDR/2016/17931.7610. Epub 2016 Apr 1.
C-Reactive Protein (CRP) is an acute phase reactant. Its level increases in the presence of acute or chronic inflammation and infections. High sensitive CRP (hs-CRP) is more sensitive than CRP as an inflammatory marker. High sensitive CRP has been known to be elevated in chronic liver diseases and Spontaneous Bacterial Peritonitis (SBP).
The aim of the study was to establish the role of ascitic fluid high sensitive C-reactive protein (hs -CRP) as a prognostic indicator in patients with SBP.
A total of 100 patients with decompensated cirrhosis admitted in medicine ward and ICU were included, of which 50 patients of acute bacterial peritonitis were used as study group and 50 patients of sterile ascites were used as control group. Hs-CRP level of cases and controls were estimated. SBP cases were treated with its standard recommended antibiotic therapy and hs-CRP level was again estimated after 5 days of antibiotic therapy or at the time of discharge.
The mean level of hs-CRP before antibiotic therapy of the patients with SBP was significantly higher than that of the patients without spontaneous bacterial peritonitis (t98=17.72; p=0.0001). The mean level of hs-CRP at 5(th) day or discharge after initiation of antibiotic therapy was significantly lower than that of level of hs-CRP before initiation of antibiotic therapy (p<0.05). The mean hs-CRP of the cases with poor outcome (death and prolonged hospital stay) was significantly higher than others.
Ascitic fluid hs-CRP level can be considered as a surrogate prognostic marker in cases of Cirrhosis with SBP.
C反应蛋白(CRP)是一种急性期反应物。在急性或慢性炎症及感染存在时其水平会升高。高敏CRP(hs-CRP)作为一种炎症标志物比CRP更敏感。已知在慢性肝病和自发性细菌性腹膜炎(SBP)中高敏CRP会升高。
本研究的目的是确定腹水高敏C反应蛋白(hs-CRP)在SBP患者中作为预后指标的作用。
共纳入100例入住内科病房和重症监护病房的失代偿期肝硬化患者,其中50例急性细菌性腹膜炎患者作为研究组,50例无菌性腹水患者作为对照组。测定病例组和对照组的hs-CRP水平。SBP病例采用标准推荐的抗生素治疗,在抗生素治疗5天后或出院时再次测定hs-CRP水平。
SBP患者抗生素治疗前hs-CRP的平均水平显著高于无自发性细菌性腹膜炎的患者(t98 = 17.72;p = 0.0001)。抗生素治疗开始后第5天或出院时hs-CRP的平均水平显著低于抗生素治疗开始前的水平(p < 0.05)。预后不良(死亡和住院时间延长)病例的平均hs-CRP显著高于其他病例。
腹水hs-CRP水平可被视为肝硬化合并SBP患者的替代预后标志物。